Potential drug for prostate cancer discovered by diabetes researchers
Monday, August 20th, 2007(NC)-While developing a new drug aimed at painful diabetic neuropathy, the research scientists at IPS Pharma Inc., a spin-off from the University of Sherbrooke, realized that the same new chemical entity (NCE – what a potential new drug is called before it actually becomes a drug) might work equally well against prostate cancer! (more…)
